LONDON (Alliance News) - The following shares received analyst recommendations Friday morning and Thursday:
----------
FTSE 100
----------
HSBC CUTS ABERDEEN ASSET MANAGEMENT PRICE TARGET TO 495 (530) PENCE - 'BUY'
----------
HSBC CUTS HIKMA PHARMACEUTICALS PRICE TARGET TO 1936 (2280) PENCE - 'HOLD'
----------
NUMIS CUTS AB FOODS TO 'REDUCE' ('HOLD') - TARGET 2598 PENCE
----------
LIBERUM RAISES GLAXOSMITHKLINE TO 'HOLD' ('SELL') - TARGET 1350 (1400) PENCE
----------
HSBC STARTS GLAXOSMITHKLINE WITH 'BUY' - PRICE TARGET 1700 PENCE
----------
HSBC STARTS ASTRAZENECA WITH 'HOLD' - PRICE TARGET 4640 PENCE
----------
JEFFERIES RAISES SAGE GROUP PRICE TARGET TO 670 (650) PENCE - 'BUY'
----------
UBS RAISES MEGGITT TO 'NEUTRAL' ('SELL') - TARGET 490 (520) PENCE
----------
DAVY INITIATES KINGFISHER WITH 'UNDERPERFORM'
----------
TRADERS: BERNSTEIN CUTS ARM TO 'UNDERPERFORM' ('MARKET-PERFORM')
----------
CREDIT SUISSE RAISES BT GROUP PRICE TARGET TO 510 (495) PENCE - 'OUTPERFORM'
---------
FTSE 250
----------
JEFFERIES RAISES DEBENHAMS PRICE TARGET TO 105 (85) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES DEBENHAMS PRICE TARGET TO 87 (77) PENCE - 'HOLD'
----------
JEFFERIES RAISES DS SMITH PRICE TARGET TO 435 (410) PENCE - 'BUY'
----------
CITIGROUP RAISES DS SMITH PRICE TARGET TO 446 (424) PENCE - 'BUY'
----------
JPMORGAN RAISES DS SMITH PRICE TARGET TO 420 (390) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK CUTS PETROFAC TO 'SELL' ('HOLD') - TARGET 875 (890) PENCE
----------
BERNSTEIN RAISES PETROFAC PRICE TARGET TO 1100 (1000) PENCE - 'OUTPERFORM'
----------
NOMURA CUTS GREENE KING PRICE TARGET TO 838 (846) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES BERKELEY GROUP PRICE TARGET TO 3750 (3300) PENCE - 'OVERWEIGHT'
----------
UBS RAISES GO-AHEAD GROUP PRICE TARGET TO 2720 (2540) PENCE - 'NEUTRAL'
----------
UBS CUTS QINETIQ TO 'SELL' ('NEUTRAL') - TARGET 205 PENCE
----------
MAIN MARKET AND AIM
----------
JEFFERIES RAISES SEVERFIELD PRICE TARGET TO 77 (74) PENCE - 'BUY'
----------
SHORE CAPITAL CUTS POLAR CAPITAL TO 'HOLD' ('BUY')
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
![Alliance News](https://static.lse.co.uk/images/news-logos/alliance-news-logo.png)
TOP NEWS: Hikma Pharmaceuticals upgrades Generics and Branded guidance
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday updated its full year guidance across its divisions after reporting continued "strong momentum" in a trading update.
Read more